BiotechTube
Home/Vasa Therapeutics/Artur Plonowski, MD, PhD
AP

Artur Plonowski, MD, PhD

CEO, Co-Founder

Vasa Therapeutics

Therapeutic Areas

CardiovascularNeuromuscularAge-related Disorders

Vasa Therapeutics Pipeline

DrugIndicationPhase
VS-041Heart Failure with Preserved Ejection Fraction (HFpEF)Phase 1
Apelin AnalogsPeripheral Artery Disease (PAD), Neuromuscular Diseases, SarcopeniaPreclinical

Leadership Team at Vasa Therapeutics

NH
Noreen Henig, MD
CMO
MG
Mike Geremia
CFO
DC
Derek Cole, PhD
CSO
BP
Benjamin Pratt, PhD
SVP of Chemistry, Co-Founder
EW
Eli Wang
VP of Finance and Operations
View full Vasa Therapeutics profile